These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34638757)

  • 41. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
    Al-Harbi NO; Nadeem A; Ahmad SF; Bakheet SA; El-Sherbeeny AM; Ibrahim KE; Alzahrani KS; Al-Harbi MM; Mahmood HM; Alqahtani F; Attia SM; Alotaibi MR
    Eur J Pharmacol; 2020 Jun; 877():173088. PubMed ID: 32234429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation.
    Lu CH; Lai CY; Yeh DW; Liu YL; Su YW; Hsu LC; Chang CH; Catherine Jin SL; Chuang TH
    Mediators Inflamm; 2018; 2018():3523642. PubMed ID: 30647534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation.
    Weng JR; Huang TH; Lin ZC; Alalaiwe A; Fang JY
    Biomed Pharmacother; 2019 Nov; 119():109398. PubMed ID: 31493747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative studies on mannan and imiquimod induced experimental plaque psoriasis inflammation in inbred mice.
    Wu H; Ou J; Li K; Wang T; Nandakumar KS
    Clin Exp Immunol; 2023 Mar; 211(3):288-300. PubMed ID: 36645209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
    Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
    J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
    Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
    Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
    Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
    Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
    Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
    J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunomodulatory effects of sleep deprivation at different timing of psoriasiform process on skin inflammation.
    Yang H; Li X; Zhang L; Xue F; Zheng J
    Biochem Biophys Res Commun; 2019 May; 513(2):452-459. PubMed ID: 30967262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways.
    Qu R; Chen X; Hu J; Fu Y; Peng J; Li Y; Chen J; Li P; Liu L; Cao J; Wang W; Qiu C; Guo L; Vasilev K; Chen J; Zhou G; Li W; Zhao Y
    Sci Rep; 2019 Feb; 9(1):1348. PubMed ID: 30718736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization.
    Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L
    Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
    Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.
    Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T
    Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
    Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
    J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production.
    Wang Y; Li P; Zhang L; Fu J; Di T; Li N; Meng Y; Guo J; Zhao J
    J Leukoc Biol; 2020 Jul; 108(1):267-281. PubMed ID: 32421901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
    Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
    Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.